Valinor Discovery Launches to Simulate Drug Performance in Virtual Patients
Valinor Discovery, a company pioneering machine learning-powered simulation of therapeutic performance to derisk drug development, today exited stealth to announce their mission to train the first clinically translatable models on matched primary cell and clinical assay datasets. Valinor is currently generating data from proprietary matched multi-omics and oncology-focused clinical assay datasets to create virtual patient profiles that can be used to accelerate clinical drug development.
